Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|170|2|285-287

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.2, 2015-07, pp. : 285-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 795-803

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B‐cell non‐Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 7, 2015-07 ,pp. : 413-420

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab with high‐dose methotrexate in primary central nervous system lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : 1149-1154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary Central Nervous System Lymphoma in the Elderly

By  

Oncology Research and Treatment, Vol. 37, Iss. 7-8, 2014-07 ,pp. : 376-377

Karger

Access to resources Recommend Favorite

Oncogenic MYD88 Mutations Are Rare Events in Double-Hit B-Cell Lymphomas

By  

Acta Haematologica, Vol. 133, Iss. 1, 2014-09 ,pp. : 113-115

Karger

Access to resources Recommend Favorite